According to a news source, J. Craig Venter and two others recently launched Human Longevity after raising an initial $70 million from private funding sources. Headquartered in San Diego, California, the company apparently intends to become the world’s largest sequencing operation and will gather genotypic, phenotypic and microbiome information from 40,000 individuals to study disease and aging. Human Longevity’s database will include information from both healthy and diseased individuals, as well as data spanning all ages from children to super-centenarians. See Nature Biotechnology, May 2014.